Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10101396 | The American Journal of Surgery | 2005 | 4 Pages |
Abstract
The use of factor VIIa in patients with life-threatening hemorrhage is a safe and effective therapeutic modality when used as an adjunct to standard interventions for control of severe hemorrhage. Lower-dose regimens were as successful as higher-dose regimens previously reported. The results of this respective study of 13 patients suggests that recombinant factor VIIa therapy for control of life-threatening hemorrhage as an adjunct to standard interventions can be successful at doses <90 mg/kg.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
A. Zaman M.D., J. Michael M.D., William F. M.D., K. Pharm.D., Alan T. Ph.D., Bruce W. M.D., James E. M.D.,